H. Tsuji

发表

Adrenomedullin Inhibits Angiotensin II-Induced Expression of Tissue Factor and Plasminogen Activator Inhibitor-1 in Cultured Rat Aortic Endothelial Cells

K. Nakagawa, M. Nakagawa, T. Sugano, 2001, Arteriosclerosis, thrombosis, and vascular biology.

HMG CoA reductase inhibitor suppresses the expression of tissue factor and plasminogen activator inhibitor-1 induced by angiotensin II in cultured rat aortic endothelial cells.

K. Nakagawa, M. Nakagawa, H. Tsuji, 2003, Thrombosis research.

Natriuretic Peptides Regulate the Expression of Tissue Factor and PAI-1 in Endothelial Cells

K. Nakagawa, M. Nakagawa, T. Sugano, 1999, Thrombosis and Haemostasis.

A Survey of the Clinical Course and Management of Japanese Patients Deficient in Natural Anticoagulants

T. Miyata, Y. Sakata, M. Murata, 2012, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Effect of probucol on intracellular pH and proliferation of human vascular endothelial cells.

M. Nakagawa, S. Sawada, H. Tsuji, 1999, Journal of pharmacological and toxicological methods.

Modulation of prostacyclin generation in cultured human vascular endothelial cells and the effects of human alpha-natriuretic polypeptide.

H. Ijichi, M. Nakagawa, H. Takamatsu, 1986, Biochimica et biophysica acta.

Antithrombin III Deficiency in a Patient With Multifocal Osteonecrosis

T. Kubo, Y. Hirasawa, M. Nakagawa, 2000, Clinical orthopaedics and related research.

Effects of nonenzymatic glycosylation on antithrombin III

H. Ijichi, M. Nakagawa, H. Takamatsu, 1987 .

Development of a Microvascular Thrombosis Model and the Participation of Oxygen Radicals on the Thrombotic Process

K. Nakagawa, M. Nakagawa, Keizo Yamada, 1993 .

The Evaluation of Antithrombotic Effects of Low Molecular Weight Heparin in Microvascular Thrombosis

K. Nakagawa, M. Nakagawa, Keizo Yamada, 1994 .

Intracoronary transplantation of non-expanded peripheral blood-derived mononuclear cells promotes improvement of cardiac function in patients with acute myocardial infarction.

H. Matsubara, Satoshi Okayama, S. Matoba, 2007, Circulation journal : official journal of the Japanese Circulation Society.

Effects of high-density lipoproteins on intracellular pH and proliferation of human vascular endothelial cells.

K. Nakagawa, M. Nakagawa, Keizo Yamada, 1996, Atherosclerosis.

The Mechanism of Thrombin Induced Prostaglandin I2 (PGI2) Enhancement in Human Umbilical Vein Endothelial Cells with Reference to the Gene Expression of PGI2 Related Enzymes and Calcium Ion Kinetics

K. Nakagawa, M. Nakagawa, S. Sawada, 1997 .

Effects of argatroban and heparin on thrombus formation and tissue plasminogen activator-induced thrombolysis in a microvascular thrombosis model.

K. Nakagawa, M. Nakagawa, Keizo Yamada, 2003, Thrombosis research.

Gene Therapy for Thrombotic Diseases

H. Masuda, H. Tsuji, 1995 .

Angiotensin II Increases Plasminogen Activator Inhibitor-1 and Tissue Factor mRNA Expression without Changing that of Tissue Type Plasminogen Activator or Tissue Factor Pathway Inhibitor in Cultured Rat Aortic Endothelial Cells

K. Nakagawa, M. Nakagawa, S. Sawada, 1997, Thrombosis and Haemostasis.

Nucleotide sequence of a new DRB1*15 variant, 1505, in a Japanese family.

M. Nakagawa, K. Tsuboyama, N. Yamagata, 1995, Tissue antigens.

Plasminogen activator inhibitor-1 promoter 4G/5G genotype is not a risk factor for myocardial infarction in a Japanese population.

K. Nakagawa, M. Nakagawa, Y. Nakahara, 1998, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Congenital antithrombin III deficiency (AT-III Kyoto): identification of a point mutation altering arginine-406 to methionine behind the reactive site.

M. Wagatsuma, M. Nakagawa, T. Hashimoto-Gotoh, 1991, Thrombosis research.

[Secretory IgA in bronchoalveolar lavage fluid].

H. Tsuji, T. Tomoda, T. Taki, 1988, Nihon Kyobu Shikkan Gakkai zasshi.

Bradykinin Inhibits Serum-Depletion-Induced Apoptosis of Human Vascular Endothelial Cells by Inducing Nitric Oxide via Calcium Ion Kinetics

K. Nakagawa, M. Nakagawa, S. Sawada, 2002, Journal of cardiovascular pharmacology.

Effects of bradykinin on prostaglandin I(2) synthesis in human vascular endothelial cells.

M. Nakagawa, S. Sawada, H. Tsuji, 2000, Hypertension.

A role of protein kinase C in the regulation of cytosolic phospholipase A2 in bradykinin-induced PGI2 synthesis by human vascular endothelial cells

M. Nakagawa, S. Sawada, H. Tsuji, 1999 .

Bradykinin enhances in vitro procoagulant and antifibrinolytic properties of rat vascular endothelial cells.

K. Nakagawa, M. Nakagawa, H. Tsuji, 2002, Thrombosis research.

Fibrinopeptide A (FPA) levels in atrial fibrillation and the effects of heparin administration.

M. Nakagawa, S. Sawada, H. Tsuji, 1988, Japanese circulation journal.

Phenotypic differences of CD34-positive stem cells harvested from peripheral blood and bone marrow obtained before and after peripheral blood stem cell collection.

E. Ashihara, M. Nakagawa, C. Shimazaki, 1994, Bone marrow transplantation.

Familial antithrombin III deficiency and its clinical significance

H. Ijichi, M. Nakagawa, T. Kitani, 1980 .

The Effects of Angiotensin Metabolites on the Regulation of Coagulation and Fibrinolysis in Cultured Rat Aortic Endothelial Cells

K. Nakagawa, M. Nakagawa, Y. Nakahara, 1999, Thrombosis and Haemostasis.

Impaired arachidonic acid metabolism of platelets and vessel wall in experimental diabetic rats and its restoration by insulin administration

H. Ijichi, M. Nakagawa, S. Sawada, 1985 .

Human atrial natriuretic polypeptide and PGI2 generation by vascular endothelial cells

H. Ijichi, M. Nakagawa, H. Takamatsu, 1987 .

Effect of Endothelin on Human Platelet Aggregation and Prostacyclin Generation from Cultured Human Vascular Endothelial Cells

M. Nakagawa, S. Sawada, H. Tsuji, 1990 .

Relationship between PGI2 generation and angiotensin I-converting enzyme related substances in cultured human vascular endothelial cells and aortic rings

M. Nakagawa, H. Takamatsu, S. Sawada, 1986 .

Monitoring plasma heparin concentration in a patient with antiphospholipid syndrome

S. Komatsu, T. Inaba, N. Fujita, 2010, International journal of hematology.

Thrombomodulin alfa treatment in patients with acute promyelocytic leukemia and disseminated intravascular coagulation: a retrospective analysis of an open-label, multicenter, post-marketing surveillance study cohort.

J. Mimuro, Y. Sakata, I. Kitajima, 2014, Thrombosis research.

Effect of inhibition of Na+-K+ ATPase on the prostacyclin generation of cultured human vascular endothelial cells.

H. Ijichi, M. Nakagawa, H. Takamatsu, 1987, Life sciences.

Effects of Intracellular pH on the Antithrombotic Properties of Human Vascular Endothelial Cells

K. Nakagawa, M. Nakagawa, Keizo Yamada, 1993 .

The Regulatory Mechanisms of Inositol Trisphosphate Generation and Ca++ Release from the Storage Sites of Human Umbilical Vein Endothelial Cells with References to the Prostacyclin Generation

M. Nakagawa, S. Sawada, H. Tsuji, 1990 .

Roles of Ca++ and calmodulin in the PGI2 generation of cultured human vascular endothelial cells

H. Ijichi, M. Nakagawa, H. Takamatsu, 1986 .

Plasma levels of soluble fibrin in patients with malignancy-associated disseminated intravascular coagulation

Y. Yamada, K. Nakagawa, N. Nakagawa, 1994, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Analysis of phenotypic variation of human plasma antithrombin III by isoelectric focusing

H. Ijichi, M. Nakagawa, H. Takamatsu, 1986 .

Implication of cyclic GMP and sulfhydryl radicals in prostacyclin generation of human vascular endothelial cells

M. Nakagawa, H. Tsuji, T. Toyoda, 1989 .

[The regulation of blood coagulation and fibrinolysis by vascular endothelial cells].

M. Nakagawa, H. Tsuji, H. Nishimura, 1999, Nihon rinsho. Japanese journal of clinical medicine.

Practical Usage of Diagnostic Guideline for Disseminated Intravascular Coagulation in Japan

K. Nakagawa, M. Nakagawa, H. Tsuji, 1999 .

Bone mass loss due to estrogen deficiency is compensated in transgenic mice overexpressing human osteoblast stimulating factor-1.

T. Mukai, T. Hashimoto-Gotoh, Y. Kuboki, 1997, Biochemical and biophysical research communications.

The kinetics of substituted AT III concentrate in the congenital AT III deficient patients.

H. Ijichi, M. Nakagawa, T. Kitani, 1985 .

Isoelectric focusing applied for the studies on elution profile of AT III from heparin sepharose

H. Ijichi, M. Nakagawa, S. Sawada, 1985 .

Protein C deficiency found in a patient with acute myocardial infarction: a single base mutation 157 Arg (CGA) to stop codon (TGA).

K. Nakagawa, M. Nakagawa, Y. Nakahara, 1994, International journal of hematology.

A Japanese family of antithrombin III deficiency

H. Ijichi, M. Nakagawa, T. Kitani, 1981 .

Antithrombin III Deficiency in a Japanese Family

H. Ijichi, M. Nakagawa, T. Kitani, 1979, Thrombosis and Haemostasis.

Genetic Analysis in Japanese Kindreds of Congenital Type I Antithrombin Deficiency Causing Thrombosis

K. Nakagawa, M. Nakagawa, Y. Nakahara, 1997, Thrombosis and Haemostasis.

Effect of atrial fibrillation on coagulation and fibrinolytic system and the anticoagulant effectiveness of subcutaneous administration of heparin

H. Ijichi, M. Nakagawa, H. Takamatsu, 1987 .

Detection of two novel mutations (nt2762, exon 2, CAG to TAG, and nt2483 or 2484, exon 2, +A) in individuals with congenital type I antithrombin deficiencies.

T. Miyata, K. Nakagawa, M. Nakagawa, 1999, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Post-marketing surveillance of thrombomodulin alfa, a novel treatment of disseminated intravascular coagulation - safety and efficacy in 1,032 patients with hematologic malignancy.

J. Mimuro, Y. Sakata, I. Kitajima, 2014, Thrombosis research.

Collection of peripheral blood stem cells mobilized by high-dose Ara-C plus VP-16 or aclarubicin followed by recombinant human granulocyte-colony stimulating factor.

K. Ito, E. Ashihara, C. Shimazaki, 1992, Bone marrow transplantation.

Association of Asn221Ser mutation in tissue factor pathway inhibitor-β with plasma total tissue factor pathway inhibitor level

Y. Kokubo, S. Madoiwa, S. Honda, 2009, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Effect of Cicletanine on the Nitric Oxide Pathway in Human Umbilical Vein Endothelial Cells

M. Nakagawa, S. Sawada, H. Tsuji, 2001, Journal of cardiovascular pharmacology.

The mechanism of thrombin-induced prostacyclin synthesis in human endothelial cells with reference to the gene transcription of prostacyclin-related enzymes and Ca2+ kinetics.

K. Nakagawa, M. Nakagawa, S. Sawada, 1999, Journal of pharmacological and toxicological methods.

Interleukin-1alpha stimulated prostacyclin release by increasing gene transcription of prostaglandin H synthase and phospholipase A2 in human vascular endothelial cells.

K. Nakagawa, M. Nakagawa, S. Sawada, 1999, Journal of cardiovascular pharmacology.

Effects of Bradykinin on the Regulatory Mechanism of PGI2 Synthesis in Human Vascular Endothelial Cells with Reference to the Intracellular Ca2+ Kinetics and mRNA Expression of Cytosolic Phospholipase A2 (cPLA2) and Prostaglandin H2 Synthase-1 (PGHS-1)

M. Nakagawa, S. Sawada, H. Tsuji, 1998 .

Effects of angiotensin - I converting enzyme related substances upon the prostacyclin generation in cultured human vascular endothelial cells with special reference to the kinetics of Ca++.

M. Nakagawa, S. Sawada, H. Tsuji, 1988 .

Regulation of prostacyclin generation by angiotensin converting enzyme related substances in cultured human vascular endothelial cells.

H. Ijichi, M. Nakagawa, H. Takamatsu, 1987, Clinical and Experimental Hypertension Part A Theory and Practice.

Effects of angiotensin I converting enzyme (ACE) related substances upon the vascular prostacyclin generation.

Y. Nakamura, M. Nakagawa, H. Takamatsu, 1987, Agents and actions. Supplements.

Prostacyclin generation by cultured human vascular endothelial cells with reference to angiotensin I-converting enzyme.

H. Ijichi, M. Nakagawa, H. Takamatsu, 1986, Japanese circulation journal.

Effect of Ca antagonists on PGI2 generation in cultured human vascular endothelial cells

H. Ijichi, M. Nakagawa, S. Sawada, 1985 .

Regulation mechanism for the enhancement of PGI2 generation by nitroglycerine

H. Ijichi, M. Nakagawa, S. Sawada, 1985 .

Effect of Ca antagonists on PGI2 generation in cultured human vascular endothelial cells with special reference to their mode of action

H. Ijichi, M. Nakagawa, T. Kitani, 1984 .

Effect of vasodilators on prostacyclin synthesis of cultured human umbilical endothelial cells

H. Ijichi, M. Nakagawa, H. Tsuji, 1983 .

Effect of cyclic nucleotides on PGI2 generation of cultured human vascular endothelial cells with references to Ca++ kinetics

H. Ijichi, M. Nakagawa, H. Takamatsu, 1988 .

Evaluation of New Japanese Diagnostic Criteria for Disseminated Intravascular Coagulation in Critically Ill Patients

M. Nakagawa, A. Murata, T. Iba, 2005, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Protein S-K196E mutation as a genetic risk factor for deep vein thrombosis in Japanese patients.

Y. Kokubo, S. Madoiwa, S. Honda, 2006, Blood.

Post-marketing surveillance data of thrombomodulin alfa: sub-analysis in patients with sepsis-induced disseminated intravascular coagulation

R. Tsujita, J. Mimuro, Y. Sakata, 2014, Journal of Intensive Care.

Application of thrombin-antithrombin III complex for detecting a latent hypercoagulable state in patients with coronary artery disease.

M. Watanabe, H. Tsuji, T. Toyoda, 1989, Japanese circulation journal.

Intracoronary Transplantation of Non-Expanded Peripheral Blood-Derived Mononuclear Cells Promotes Improvement of Cardiac Function in Patients With Acute Myocardial Infarction

H. Matsubara, Satoshi Okayama, S. Matoba, 2007 .

Impact of recombinant soluble thrombomodulin (thrombomodulin alfa) on disseminated intravascular coagulation.

J. Mimuro, Y. Sakata, I. Kitajima, 2013, Thrombosis research.

Postmarketing Surveillance of Recombinant Human Soluble Thrombomodulin (Thrombomodulin α) in Pediatric Patients With Disseminated Intravascular Coagulation

J. Mimuro, Y. Sakata, A. Shirahata, 2014, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Pediatric Patients With Disseminated Intravascular Coagulation ) in α Postmarketing Surveillance of Recombinant Human Soluble Thrombomodulin ( Thrombomodulin

J. Mimuro, Y. Sakata, A. Shirahata, 2014 .

Recombinant soluble human thrombomodulin (thrombomodulin alfa) in the treatment of neonatal disseminated intravascular coagulation

J. Mimuro, Y. Sakata, A. Shirahata, 2014, European Journal of Pediatrics.

Prevalence of genetic mutations in protein S, protein C and antithrombin genes in Japanese patients with deep vein thrombosis.

Yukiko Sato, S. Madoiwa, S. Honda, 2009, Thrombosis research.

Symptomatic deep venous thrombosis of the lower extremity in a pregnant woman successfully treated with endovascular procedures

Kei Yamada, O. Tanaka, J. Kitawaki, 2013, The journal of obstetrics and gynaecology research.

Effects of Angiotensin I Converting Enzyme (ACE)-Related Substances on Prostacyclin Generation and ACE Activity of Human Vascular Endothelial Cells and Rat Aortic Rings

H. Ijichi, M. Nakagawa, H. Takamatsu, 1987, Journal of cardiovascular pharmacology.

Implication of Na+ kinetics in PGI2 generation of cultured human vascular endothelial cells

M. Nakagawa, S. Sawada, Kyo Kobayashi, 1988 .